MedTrace Logo

Efficacy and Safety of Escócia Association in the Treatment of Acute Pain

NCT04666701 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2023-09-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of Escócia association in adults with acute pain.

Conditions

  • Acute Pain

Interventions

DRUG

Escócia association

Escócia association tablet

OTHER

Placebo Ketorolac

Placebo Ketorolac tablet

OTHER

Placebo Scopolamine

Placebo Scopolamine dragee

DRUG

Ketorolac Tromethamine

Ketorolac tablet

DRUG

Scopolamine

Scopolamine dragee

OTHER

Placebo Escócia association

Placebo Escócia association tablet

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-28
Primary Completion
2025-02-28
Completion
2025-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04666701 on ClinicalTrials.gov